Skip to main content

$811.31 Million in Sales Expected for AMN Healthcare Services, Inc. (NYSE:AMN) This Quarter

Last updated on Wednesday, May 5, 2021 | 2021 MarketBeat

Brokerages expect AMN Healthcare Services, Inc. (NYSE:AMN) to post sales of $811.31 million for the current fiscal quarter, Zacks Investment Research reports. Four analysts have made estimates for AMN Healthcare Services' earnings. The lowest sales estimate is $806.99 million and the highest is $815.40 million. AMN Healthcare Services posted sales of $602.46 million in the same quarter last year, which suggests a positive year over year growth rate of 34.7%. The firm is expected to issue its next quarterly earnings results after the market closes on Thursday, May 6th.

On average, analysts expect that AMN Healthcare Services will report full year sales of $2.80 billion for the current fiscal year, with estimates ranging from $2.74 billion to $2.85 billion. For the next year, analysts anticipate that the company will report sales of $2.59 billion, with estimates ranging from $2.53 billion to $2.65 billion. Zacks' sales averages are a mean average based on a survey of research analysts that follow AMN Healthcare Services.

AMN Healthcare Services (NYSE:AMN) last announced its quarterly earnings results on Wednesday, February 17th. The company reported $1.00 EPS for the quarter, beating the Zacks' consensus estimate of $0.88 by $0.12. The company had revenue of $631.27 million during the quarter, compared to analysts' expectations of $625.62 million. AMN Healthcare Services had a return on equity of 20.38% and a net margin of 3.78%.

A number of brokerages have weighed in on AMN. Truist increased their price target on AMN Healthcare Services from $84.00 to $95.00 in a report on Friday, February 19th. BMO Capital Markets raised their target price on AMN Healthcare Services from $81.00 to $86.00 and gave the company an "outperform" rating in a research note on Monday, March 1st. Finally, Jefferies Financial Group restated a "buy" rating on shares of AMN Healthcare Services in a research note on Friday, April 9th. One investment analyst has rated the stock with a sell rating and eight have assigned a buy rating to the stock. The company presently has an average rating of "Buy" and a consensus target price of $74.50.

In other AMN Healthcare Services news, Director Martha H. Marsh sold 18,175 shares of AMN Healthcare Services stock in a transaction dated Monday, March 15th. The stock was sold at an average price of $77.32, for a total transaction of $1,405,291.00. Following the completion of the transaction, the director now owns 29,090 shares in the company, valued at approximately $2,249,238.80. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Denise L. Jackson sold 2,000 shares of AMN Healthcare Services stock in a transaction dated Wednesday, March 10th. The shares were sold at an average price of $76.84, for a total value of $153,680.00. Following the transaction, the insider now owns 16,752 shares of the company's stock, valued at approximately $1,287,223.68. The disclosure for this sale can be found here. Insiders have sold a total of 22,901 shares of company stock valued at $1,758,269 in the last quarter. Company insiders own 1.35% of the company's stock.

Several institutional investors have recently bought and sold shares of AMN. International Assets Investment Management LLC bought a new position in shares of AMN Healthcare Services during the 4th quarter worth approximately $29,000. James Investment Research Inc. bought a new position in shares of AMN Healthcare Services during the 4th quarter worth approximately $61,000. Focused Wealth Management Inc bought a new position in shares of AMN Healthcare Services during the 4th quarter worth approximately $61,000. Truvestments Capital LLC bought a new position in shares of AMN Healthcare Services during the 4th quarter worth approximately $72,000. Finally, Veriti Management LLC bought a new position in shares of AMN Healthcare Services during the 4th quarter worth approximately $109,000. 94.61% of the stock is currently owned by hedge funds and other institutional investors.

Shares of AMN Healthcare Services stock opened at $81.37 on Wednesday. The company has a current ratio of 1.33, a quick ratio of 1.33 and a debt-to-equity ratio of 1.11. The business has a 50-day moving average price of $76.36 and a two-hundred day moving average price of $71.49. AMN Healthcare Services has a 1-year low of $36.65 and a 1-year high of $81.73. The company has a market cap of $3.84 billion, a P/E ratio of 43.51, a PEG ratio of 3.81 and a beta of 0.51.

About AMN Healthcare Services

AMN Healthcare Services, Inc provides healthcare workforce solutions and staffing services to hospitals and healthcare facilities in the United States. The company operates through three segments: Nurse and Allied Solutions, Physician and Leadership Solutions, and Technology and Workforce Solutions. It offers travel nurse staffing under the American Mobile, Onward Healthcare, and O'Grady Peyton brands; rapid response nurse staffing and labor disruption services under the NurseChoice and HealthSource Global Staffing brands; local or per diem staffing services under Nursefinders brand; and locum tenens staffing services under the Staff Care and Locum Leaders brands.

Featured Article: Back-End Load

Get a free copy of the Zacks research report on AMN Healthcare Services (AMN)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for AMN Healthcare Services (NYSE:AMN)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected]

Featured Article: What is an Initial Public Offering (IPO)?


7 Undervalued Stocks That Deserve More Attention

With the Dow Jones Industrial Average (DJIA) hitting new highs seemingly every day, it may seem like the wrong time to be looking at undervalued stocks. Or is it?

From cannabis to cryptocurrencies, and let’s not forget electric vehicles the market seems to be blowing bubbles wherever you look. And that’s why now may be exactly the right time to zig while the market is sagging. And that means looking for undervalued stocks.

But finding undervalued stocks is subjective. Some analysts use specific fundamental metrics. Others use technical analysis.

However, the general idea is that you’re looking for stocks that are trading below their fair value.

In some cases, these may be stocks whose financials are stronger than other stocks in their sector, but it’s trading at a lower price. In other cases, a company may have potential that is not reflected in its stock price. Put another way, undervalued stocks are stocks that have room to grow. That’s why they deserve a place in your portfolio.

And that’s why we’ve put together this special presentation on stocks that are undervalued right at this time. An investment in these companies is likely to be rewarded because the stocks are moving under the radar from the broader market.

View the "7 Undervalued Stocks That Deserve More Attention".


MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.